Key points:
1. Tasmania could become the first Australian state to ban over-the-counter sales of e-cigarettes and require a prescription under proposed legislation.
2. The new bill mandates that Tasmanians aged 18 and over must obtain a valid prescription to purchase e-cigarettes, vape liquids, and vaping devices from pharmacies.
3. The state’s Minister for Mental Health and Wellbeing said the measure aims to curb youth vaping and protect the health of future generations.
2Firsts, reporting from Shenzhen - Tasmania could become the first state in Australia to completely ban the sale of non-prescription e-cigarettes and instead adopt a prescription sales model, according to the Tasmanian government's official website.
On the 13th, the state preliminarily passed the Public Health Amendment (Vaping) Bill 2024 in the Legislative Council, allowing only Tasmanians over the age of 18 to purchase e-cigarette products from pharmacies with a valid prescription.
This surpasses federal regulations and laws in other states, where adults can still purchase e-cigarettes from pharmacies without a doctor's approval.
The state Minister for Mental Health and Wellbeing, Roger Jaensch, stated that:
"The vaping Bill is designed to curb the rising tide of youth vaping, safeguarding the health of future generations."
"In October last year, the national laws about the sale of e-cigarette products changed, meaning in some states adults can buy certain e-cigarette products over the counter in pharmacies without a prescription."
"Tasmania has retained the requirement that e-cigarettes can only legally be accessed through a pharmacy and that adults must have a doctor’s prescription to access e-cigarettes, e-liquid and vaping devices."
"I am pleased the vaping Bill has now passed through both houses of the Tasmania Parliament so we can continue working towards all actions possible to protect our community from the harms of vaping."
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
